OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
September 07, 2024
New technologies improve efficiency and remove operator intervention.
September 06, 2024
Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.
September 05, 2024
Rentschler Biopharma has expanded its service offerings at its Stevenage, UK, site with a new lentiviral vector manufacturing toolbox.
September 01, 2024
Thermo Scientific’s columns offer fast run times, optimal separation efficiency, and reliable results.
Freudenberg Medical’s new offerings include single-use Y-connector manifolds, tubing assemblies, and bottlecap assemblies, among others.
Charles Ross & Son Company has introduced the ROSS CDA-300 Dual Shaft Mixer, consisting of two agitators and a disperse with an open disc blade.
Asahi Kasei Medical now offers its Planova virus removal filters for use in biopharma manufacturing and plasma derivatives manufacturing.
August 30, 2024
The approach makes use of clinical mass spectrometers that are already available in hospitals around the world.
August 29, 2024
This is the company’s largest single investment in the Sweden Biomanufacturing Center, in Södertälje, which opened in 2021.
August 22, 2024
Vernal Biosciences’ CEO and founder, Christian Cobaugh, discusses the outsourcing landscape for mRNA production.